VeriMom¿Es eucalyptus globulus leaf extract seguro durante el embarazo?
No harmonised CLP reproductive classification found and no CIR or SCCS safety assessment identifying reproductive hazard for Eucalyptus globulus leaf extract. Peer‑reviewed literature does not show confirmed teratogenic or reproductive effects for the botanical extract at typical topical exposure levels; however constituents (e.g., 1,8‑cineole in eucalyptus oil) can be systemically absorbed, so low but measurable maternal exposure from topical use is plausible (sources: ECHA Annex VI (no harmonised reproductive flag), CIR (no assessment flagged), PubMed literature on eucalyptus/1,8‑cineole).
Pregnancy-safe products containing eucalyptus globulus leaf extract
Related ingredients
Frequently asked questions
- ¿Es eucalyptus globulus leaf extract seguro durante el embarazo?
- No harmonised CLP reproductive classification found and no CIR or SCCS safety assessment identifying reproductive hazard for Eucalyptus globulus leaf extract. Peer‑reviewed literature does not show confirmed teratogenic or reproductive effects for the botanical extract at typical topical exposure levels; however constituents (e.g., 1,8‑cineole in eucalyptus oil) can be systemically absorbed, so low but measurable maternal exposure from topical use is plausible (sources: ECHA Annex VI (no harmonised reproductive flag), CIR (no assessment flagged), PubMed literature on eucalyptus/1,8‑cineole).
- ¿Es eucalyptus globulus leaf extract seguro durante la lactancia?
- No evidence of reproductive or lactation-specific toxicity or harmonised classification. Systemic absorption of volatile constituents is possible after topical application, so low but measurable exposure to lactating parent is plausible; no data indicate transfer to breastmilk or harmful effects in breastfed infants (sources: PubChem, PubMed, absence of ECHA harmonised classification).
- ¿Es eucalyptus globulus leaf extract seguro para la piel del bebé?
- No specific data showing developmental or reproductive toxicity in infants from topical cosmetic use of the leaf extract and no harmonised CLP reproductive hazard. However, infant skin has higher permeability and eucalyptus materials (notably eucalyptus oil/1,8‑cineole) are reported in the literature to cause adverse effects in young children when ingested or used inappropriately; therefore dermal exposure is judged as moderate (adult exposure scored as low measurable, increased by +1 for infants). No infant‑specific mechanistic evidence of reproductive endocrine disruption was found (sources: PubMed reports of pediatric toxicity from eucalyptus oil ingestion, EWG entries; no ECHA Annex VI reproductive flags).
- ¿Cómo puntúa VeriMom a eucalyptus globulus leaf extract?
- VeriMom puntúa eucalyptus globulus leaf extract en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a eucalyptus globulus leaf extract en el embarazo?
- Consulta nuestra lista de alternativas seguras a eucalyptus globulus leaf extract según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.